Technavio, a leading provider of market research reports, has released its latest study on Plasma Fractionation Market. This report offers a comprehensive analysis of the current market trends, emerging opportunities, and key challenges.
In the realm of global healthcare industries, the plasma fractionation market represents a significant segment within the broader pharmaceuticals sector. Technavio's market analysis encompasses entities involved in R&D and manufacturing of various pharmaceutical offerings, including generic, non-generic drugs, and veterinary medicines. The size of the healthcare market is determined by the collective revenue generated from equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. The expansion of the pharmaceuticals market is primarily fueled by demographic trends, specifically the increasing elderly population, with the global population aged 60 and above projected to grow substantially. - The Plasma Fractionation Market is experiencing significant growth, fueled by the Growing prevalence of plasma products treated in respiratory diseases and AATD. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Know what is trending in the market - Access a free sample report!
The market size is estimated to grow by USD 10.00 billion, at a CAGR of 6.09% during the forecast period. Growing elderly population and related disorders | Government strategies for increasing self-sufficiency for plasma products | Rising demand for plasma collection
For insights on company offerings- Request a sample report!
The North American plasma fractionation market is projected to experience steady expansion, driven by significant demand in the US, Canada, and Mexico. These countries' robust plasma collection infrastructure and culture of voluntary donation ensure a reliable plasma source. Factors fueling growth include the rise in surgical procedures, increasing blood donor base, and escalating cancer prevalence. Additionally, government and NGO end-use sectors' expanding requirements contribute to market expansion.
The Plasma Fractionation Market encompasses the production and sale of various therapeutic proteins derived from plasma, including Thrombin and Prothrombin complex. These factors play crucial roles in the coagulation cascade and are essential for managing anticoagulant imbalances in chronic disorders and rare diseases, such as primary immunodeficiencies and liver diseases. Plasma collection centers serve as vital sources of raw material for this industry, with plasma being fractionated through advanced techniques to yield immunoglobulins, albumins, and other therapeutic proteins. These products find extensive applications in the treatment of various therapeutic areas, including respiratory diseases like emphysema and lung diseases, as well as thrombotic conditions. The Plasma Industry continues to grow, driven by the increasing demand for these life-saving therapies.
Technavio is a global market research company offering comprehensive reports and insights on various industries. Our research helps businesses make informed decisions by providing actionable data and trends. Technavio is based on four simple principles: easy-to-access reports, robust industry coverage, a focus on new and emerging technologies, and competitive pricing. We believe in helping companies and executives become better equipped to make faster, sounder, and more effective decisions. Technavio is one of the most influential market research and advisory firms in the world. We work with business and technology leaders to provide cutting-edge market research and insights to companies.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/